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Supplemental Figure 1. Integration of native biomolecules as HTC gel constituents. 
Expanded form of Figure 4. Hydrogel-tissue chemistry (HTC) backbone variants (selected subset 
shown, top row) allow selective and customizable biological macromolecule anchoring and 
functionalization (middle row). Molecular architecture and macromolecule-anchoring properties 
of the initial CLARITY formulation (top left; 16) and some subsequent variants are shown. The 
chemical backbone of the CLARITY hydrogel interacts with tissue elements through two 
principal routes: (i) covalent conjugation to amine-containing and otherwise functionalized 
proteins, nucleic acids, and small biomolecules; and (ii) noncovalent trapping of bulky moieties, 
such as extensively cross-linked protein networks within the hydrogel matrix. Exhibiting these 
similar interactions with tissue components, the subsequent HTC variants are also capable of 
preserving molecular information during tissue processing through physically securing tissue 
macromolecules to the hydrogel or through recording their cellular location using custom labels 
that can withstand processing steps. All of these approaches incorporate native biomolecules as 
an integral and essential part of the tissue-hydrogel matrix, including via (i) targeted retention of 
specific biological macromolecules [nucleic acids with EDC-CLARITY (123), PACT 
(140)/smFISH/smHCR and ExFISH (12); and lipids with SWITCH (92)]; (ii) increased rigidity 
(SWITCH); or conversely (iii) increased size-flexibility [clearing reagents and modifications: 
PACT (140)/ExM (11)/ePACT (131)/proExM (125)/ExFISH (12) shown, iExM (10) and MAP 
(62) not shown]. (bottom row) To visualize the macromolecular composition of whole tissue 
samples, this molecular information was originally accessed via detergent-based delipidation, 
with or without electrophoretic acceleration (16). Many subsequent methods (PACT (140), 
ePACT (131), EDC-CLARITY (123), and PACT with smFISH or smHCR) retained this use of 
sodium dodecyl sulfate (SDS) for clearing samples at moderate temperatures and at neutral or 
slightly alkaline pH due to the important compatibility of these mild conditions for maintenance 
of endogenous fluorescence and of nucleic acid and protein content. Other methods (SWITCH, 
MAP) (62, 92) found distinct benefits in varying temperature and pH, alterations that can 
accelerate lipid removal and improve size flexibility of the tissue-hydrogel matrix at the cost of 
losing some molecular content. ExM (11) employs enzymatic digestion of all tissue proteins and 
hydration; although biomolecular information and endogenous fluorescence are compromised, 
individual labeling with customized probes forms a record of their original presence. Of 
subsequent modifications [ExM with antibodies, ExFISH (12), iExM (10), and proExM (125)], 
proExM converges back toward resembling the CLARITY/PACT/ePACT protocols, with only 
mild enzymatic digestion or heated incubation in an alkaline SDS solution en route to 
expansion/clearing. The custom trifunctional linker/label depicted in the original ExM protocol 
(11) consisted of three conjoined components: 1. a biomacromolecule recognition moiety, such 
as an oligonucleotide capable of hybridizing with a complementary sequence that has already 
been appended to an antibody, 2. a fluorescent tag, and 3. a monomer-like methacryloyl 
functional group covalently incorporated into the hydrogel network during polymerization. In 
proExM (125) and variation ExPath (146), these three linker components are replaced with a 
single small-molecule linker for biomacromolecule recognition and hydrogel incorporation; 
succinimidyl ester of 6-((acryloyl)amino)hexanoic acid (AcX) for modifying amines, including 
fluorescently-tagged secondary antibodies, with a polymerizable acrylamide functional group. In 
ExFISH (12), a bifunctional linker is formed from two components: the AcX small-molecule of 
ProExM, and a second small-molecule containing both an amino group, which mediates the 
attachment to AcX, and an alkylating group, which serves as the biomacromolecule recognition 
moiety via its reaction with the N7 of guanine in RNA. Finally, iterative ExM (iExM (10) uses 
two (or more) composite polyelectrolyte gels and two AcX-based linker types; the first is an 
oligonucleotide conjugated to a polymerizable acrydite moiety, while the second is a 
complementary oligonucleotide with a second acrydite moiety and a fluorescent tag at either end. 
Like ExM, the first oligonucleotide linker is designed to hybridize to a complementary sequence 
appended to an antibody. Abbreviations: EDC, 1-Ethyl- 3-3-dimethyl-aminopropyl 
carbodiimide; ePACT, expansion passive CLARITY technique; ETC, electrophoretic tissue 
clearing; ExFISH, expansion fluorescent in situ hybridization; ExM, expansion microscopy; 
iExM, iterative expansion microscopy; MAP, magnified analysis of the proteome; PACT, 
passive CLARITY technique; proExM, protein-retention expansion microscopy; SWITCH, 
system-wide control of interaction time and kinetics of chemicals; smFISH, single-molecule 
fluorescent in situ hybridization; smHCR, single-molecule hairpin chain reaction.  
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